<DOC>
	<DOCNO>NCT00211614</DOCNO>
	<brief_summary>Obstructive Sleep Apnea ( OSA ) common modern society , affect 5 % work middle-aged adult United States . Obesity number one risk factor development OSA . Consequences untreated OSA vary significant include numerous neuropsychiatric parameter mood alteration , depression , anxiety , diminish social interaction , decrease quality life . Mounting evidence suggest treatment OSA improve many outcome . The primary treatment modality condition continuous positive airway pressure ( CPAP ) . This device deliver positive pressure upper airway order prevent collapse sleep . Unfortunately , many patient choose use CPAP difficulty device . This result many individual OSA either go without therapy unable reap full benefit treatment . Gastroesophageal reflux ( GERD ) also common United States may , instance , directly relate weight gain . Survey study suggest symptomatic GERD common patient OSA . Whether exist cause effect relationship two condition know present . It suggest GERD may contribute OSA narrow upper airway . This study examine effect treatment GERD mild moderate OSA . Fifty individual identify mild moderate OSA ( diagnose overnight sleep study PSG ) GERD ( confirm esophageal probe ) enrol . Both men woman include study “ special population ” utilized . Subjects fill questionnaires subjectively measure sleepiness , OSA-related symptom , GERD-related symptom , sleep apnea-related quality life . They randomize receive either 12 week proton pump inhibitor lansoprazole ( Prevacid ) placebo ( twenty five subject per group ) . Upon completion 12 week trial , subject return follow data collect ; repeat baseline questionnaire , repeat PSG repeat pH probe . Results study help establish relative effectiveness novel form therapy common yet difficult manage medical condition . . The risk subject enrol study minimal therefore benefit risk ratio heavily favor perform study .</brief_summary>
	<brief_title>Proton Pump Inhibitor Therapy Mild Moderate Obstructive Sleep Apnea</brief_title>
	<detailed_description>See .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>1 . Adults ( &gt; 18 year old ) mild moderate OSA ( define apneahypopnea index 5 30 ) currently therapy . 2 . GERD document 24 pH probe ( &gt; 6 % time pH &lt; 4 ) . 3 . Agreeable participate study 1 . Those meeting inclusion criterion 2 . Prisoners , minor , incompetent subject , unconscious subject , house staff student , pregnant woman 3 . Oxygen dependent , require supplemental oxygen sleep , significant hypoxia initial PSG ( O2 sats &lt; 85 % &gt; 5 minute sleep ) 4 . Severe cardiac pulmonary disease ( CHF EF &lt; 40 % , active coronary ischemia unstable angina , uncontrolled arrythmias , COPD lung condition require supplemental oxygen document hypercapnia pCO2 &gt; 45 ) . 5 . Neuromuscular disease hypercapnia ( pCO2 &gt; 45 ) 6 . Any cancer prognosis &lt; 1 year survival 7 . Use H2 blocker therapy PPI therapy within 14 day initial PSG . 8 . Individuals require routine use sleep aid ( i.e . benzodiazepine sedative ) 9 . Individuals active alcohol substance abuse 10 . Night shift worker work rotate shifts 11 . Disabling sleepiness ( Epworth Sleepiness Scale &gt; 17 history accident related sleepiness ) place individual risk accident . 12 . Inability complete study questionnaires 13 . Allergy lansoprazole</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>Gastroesophageal Reflux</keyword>
	<keyword>Proton Pump Inhibitor</keyword>
	<keyword>Lansoprazole ( Prevacid )</keyword>
	<keyword>Quality Life</keyword>
</DOC>